An Open-Label, Phase 1B Study of NEO-PV-01 With Pembrolizumab Plus Chemotherapy in Patients With Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer
Phase of Trial: Phase I
Latest Information Update: 18 May 2018
At a glance
- Drugs NEO-PV 01 (Primary) ; Pembrolizumab (Primary) ; Carboplatin; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- Sponsors Neon Therapeutics
- 08 May 2018 According to a Neon Therapeutics media release, first patient has been treated.
- 06 Mar 2018 Status changed from not yet recruiting to recruiting.
- 19 Dec 2017 Status changed from planning to not yet recruiting.